Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate

NCT03319914 is registered in ClinicalTrials.gov with Hope Pharmaceuticals as lead sponsor.

NCT NCT03319914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03319914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate
Lead sponsor
Hope Pharmaceuticals
Phase
Observational
Overall status
Terminated
Start date
October 20, 2017
Completion date
November 9, 2018
Enrollment
5 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

calciphylaxis